Elevance Health (ELV) Depreciation & Amortization (CF) (2010 - 2026)

Elevance Health (ELV) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $354.0 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $354.0 million, down 5.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 6.41% YoY), and the FY2025 annual result was $1.5 billion, up 10.98% from the prior year.
• Depreciation & Amortization (CF) slipped to $354.0 million in Q1 2026 per ELV's latest filing, from $406.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $473.0 million in Q4 2022 and troughed at $329.0 million in Q3 2024.
• A 5-year average of $394.9 million and a median of $393.0 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) surged 31.39% in 2022, then retreated 28.35% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $473.0 million in 2022, then fell by 10.36% to $424.0 million in 2023, then decreased by 6.13% to $398.0 million in 2024, then grew by 2.01% to $406.0 million in 2025, then decreased by 12.81% to $354.0 million in 2026.
• Business Quant data shows ELV's Depreciation & Amortization (CF) at $354.0 million in Q1 2026, $406.0 million in Q4 2025, and $387.0 million in Q3 2025.